Rankings
▼
Calendar
CRMD FY 2023 Earnings — CorMedix Inc. Revenue & Financial Results | Market Cap Arena
CRMD
CorMedix Inc.
$536M
FY 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
-100.0% YoY
Gross Profit
-$205,562
Operating Income
-$49M
Net Income
-$46M
EPS (Diluted)
$-0.91
Cash Flow
Operating Cash Flow
-$38M
Free Cash Flow
-$39M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$82M
Total Liabilities
$12M
Stockholders' Equity
$70M
Cash & Equivalents
$44M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$65,408
-100.0%
Gross Profit
-$205,562
$61,674
-433.3%
Operating Income
-$49M
-$31M
-59.9%
Net Income
-$46M
-$30M
-56.0%
← Q4 2022
All Quarters
Q1 2023 →